Onconetix (ONCO) vs Alaunos Therapeutics (TCRT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Onconetix is the larger company by market cap ($3.2 million vs $2.3 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ONCO | TCRT |
|---|---|---|
| Share price | $0.62 | $0.7858 |
| Market cap | $3.25M | $2.30M |
| 1-day change | -5.24% | +0.61% |
| P/E ratio (TTM) | 0.00 | — |
| EPS (TTM) | $295.93 | $-1.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $200.00 | $4.50 |
| 52-week low | $0.58 | $0.72 |
| Distance from 52-week high | -99.69% | -82.54% |
| Average volume | 2.94M | 809.68K |
| Shares outstanding | 5.24M | 2.93M |
| Employees | 2 | 1 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Onconetix
ONCO stock →Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
About Alaunos Therapeutics
TCRT stock →Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs.
Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees
ONCO vs TCRT FAQ
Which is bigger, Onconetix or Alaunos Therapeutics?
Onconetix (ONCO) is larger, with a market capitalization of $3.25M compared with $2.30M for Alaunos Therapeutics (TCRT).
Are Onconetix and Alaunos Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.